Tumor News and Research

RSS

New measurement tool helps analyze quality of life after childhood cancer

A new measurement tool helps analyze the survival rate of children with cancer, but also the quality of survival.

20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia have identified new biomarkers for non-small cell lung cancer, the most common lung cancer.

20 Jun 2023

Study provides a promising strategy for the treatment of neuroblastoma

Announcing a new publication for Acta Materia Medica journal. Neuroblastoma (NB) is a common solid tumor in children and infants, the formation and regression of which is closely linked to the tumor-host immune relationship.

19 Jun 2023

Research reveals devastating impact of Western diet on human health

Research examines the impact of the Western diet on various aspects of health, including metabolism, inflammation, gut microbiota, cardiovascular health, mental health, and cancer. It provides insights into the effects of this dietary pattern on individuals and healthcare systems.

18 Jun 2023

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer.

16 Jun 2023

Combination of two drugs may be more effective in treating resistant breast cancer

Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research.

16 Jun 2023

Rice U. chemist wins NSF award to investigate how heterogeneity affects chemical and biological processes

Rice University chemist Anatoly Kolomeisky has won an award from the National Science Foundation to investigate how heterogeneity affects chemical and biological processes.

16 Jun 2023

New research finds most women diagnosed with early breast cancer can expect to become long-term survivors

Researchers reported longitudinal outcomes among British women suffering from early invasive-type breast tumors as their initial tumor and those initially treated by surgical methods such as conservative surgery or mastectomy.

16 Jun 2023

$Fruquintinib improved survival in patients with refractory metastatic colorectal cancer$

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in patients with refractory metastatic colorectal cancer.

16 Jun 2023

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

16 Jun 2023

Experts identify a novel fucosylated heparan sulfate from the midgut gland of the Japanese scallop

Glycosaminoglycans (GAGs), including chondroitin sulfate (CS), heparan sulfate (HS), heparin, and hyaluronan are linear and acidic polysaccharides found in the extracellular matrix of all animal tissues. GAGs are widely used as functional ingredients in health products, pharmaceuticals, and cosmetics, and are prepared from biological samples such as shark cartilage and porcine intestinal mucosa. Consequently, the demand for new sources of GAGs is ever-present. For example, the supply source of the anticoagulant heparin - generally prepared from porcine intestinal mucosa in China - was threatened by African swine fever in 2018.

15 Jun 2023

Tumor News and Research

New measurement tool helps analyze quality of life after childhood cancer

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Study provides a promising strategy for the treatment of neuroblastoma

Research reveals devastating impact of Western diet on human health

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

Combination of two drugs may be more effective in treating resistant breast cancer

Rice U. chemist wins NSF award to investigate how heterogeneity affects chemical and biological processes

New research finds most women diagnosed with early breast cancer can expect to become long-term survivors

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

Experts identify a novel fucosylated heparan sulfate from the midgut gland of the Japanese scallop

Research explores complex relationship between cholesterol and breast cancer risk

Substance P neuropeptides' role in post-COVID-19 conditions suggested in recent study

Destroying the tether of shattered chromosomal fragments may help prevent cancerous mutations

Innovative method to map specific DNA markings could be used for early cancer detection

UC researchers discover treatment for a rare cancer-like lung disease in women

Complete genomics announces updated mission and new partnerships on 18th anniversary

New and significant breakthrough made to detect brain tumors

Molecular insights into long COVID: serum proteome reveals dominant signaling pathways

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News